Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-progranulin monoclonal antibody AG01

A monoclonal antibody targeting human progranulin (PGRN; glycoprotein 88; GP88), with potential antineoplastic activity. Upon administration, anti-PGRN monoclonal antibody AG01 targets and binds to PGRN expressed on tumor cells. This neutralizes PGRN and prevents the activation of downstream signaling pathways, which may include extracellular signal-regulated kinases 1 (ERK1) and 2 (ERK2), phosphatidylinositol 3-kinase (PI3K), and focal adhesion kinase (FAK), thereby inhibiting tumor cell proliferation, migration and invasion. PGRN, an autocrine growth factor overexpressed in various types of cancers, plays an important role in tumorigenesis, tumor cell proliferation and invasiveness, and drug resistance.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-glycoprotein 88 monoclonal antibody AG01
Anti-GP88 monoclonal antibody AG01
anti-PGRN monoclonal antibody AG01
Code name:AG 01
AG-01
AG01
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search